Skip to content

Drug interactions

Gliclazide + Mipomersen

Severity: Minor

Gliclazide and Mipomersen: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mipomersen can raise liver enzymes and cause hepatic fat accumulation, and sulfonylureas rarely cause liver injury. No meaningful pharmacokinetic or glycemic interaction is established, so the concern is additive hepatic burden.

What this interaction means in plain words

Gliclazide and Mipomersen have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible additive hepatotoxicity; no pharmacokinetic interaction is established.

What to do

Monitor liver enzymes as required for mipomersen therapy and review treatment if significant elevations occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gliclazide and Mipomersen, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Gliclazide with Mipomersen?

MediHelp rates the interaction as minor. Gliclazide and Mipomersen have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Mipomersen can raise liver enzymes and cause hepatic fat accumulation, and sulfonylureas rarely cause liver injury. No meaningful pharmacokinetic or glycemic interaction is established, so the concern is additive hepatic burden.

How serious is the interaction between Gliclazide and Mipomersen?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes as required for mipomersen therapy and review treatment if significant elevations occur.

What other medicines interact with Gliclazide?

MediHelp also lists interactions of Gliclazide with, for example, Ciprofloxacin, Clarithromycin, Disopyramide. The full list is on the Gliclazide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in